Skip Navigation

European Heart Journal 2004 25(13):1089-1090; doi:10.1016/j.ehj.2004.04.035
Copyright © 2004 by the European Society of Cardiology.
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Abdelhadi, R. H
Right arrow Articles by Van Wagoner, D. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abdelhadi, R. H
Right arrow Articles by Van Wagoner, D. R
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

New hope for the prevention of recurrent atrial fibrillation

Raed H Abdelhadi, Mina K Chung and David R Van Wagoner*

Department of Cardiovascular Medicine, Cleveland Clinic Foundation,Cleveland, OH, USA

* Correspondence to: David R. Van Wagonering, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA. Tel.: +1-216-444-0820; fax: +1-216-444-9155
E-mail address: vanwagd@ccf.org

The first 10% of the full text of this article appears below.

This editorial refers to "Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation"1 by J. Dernellis et al. on page 1100

Elevated C-reactive protein (CRP) levels are associated with numerous cardiovascular diseases, and have been shown to predict future cardiac events.1 Bruins and colleagues were the first to report an association between CRP elevation and the occurrence of atrial fibrillation (AF), in their case in the context of AF following cardiac surgery.2 They demonstrated that CRP levels peaked on the second post-operative day, and that increased levels of complement-CRP complexes peaked on the second . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation
John Dernellis and Maria Panaretou
EHJ 2004 25: 1100-1107. [Abstract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
J. R. Brown, R. P. Cochran, T. A. MacKenzie, A. P. Furnary, K. S. Kunzelman, C. S. Ross, C. W. Langner, D. C. Charlesworth, B. J. Leavitt, L. J. Dacey, et al.
Long-Term Survival After Cardiac Surgery is Predicted by Estimated Glomerular Filtration Rate
Ann. Thorac. Surg., July 1, 2008; 86(1): 4 - 11.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. J. Ahlsson, L. Bodin, O. H. Lundblad, and A. G. Englund
Postoperative Atrial Fibrillation is Not Correlated to C-Reactive Protein
Ann. Thorac. Surg., April 1, 2007; 83(4): 1332 - 1337.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
D. S.G. Conway and G. Y.H. Lip
Inflammation, arrhythmia burden and the thrombotic consequences of atrial fibrillation
Eur. Heart J., October 1, 2004; 25(19): 1761 - 1761.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
D. G. Katritsis
Anti-inflammatory medication for atrial fibrillation
Eur. Heart J., October 1, 2004; 25(19): 1762 - 1762.
[Full Text] [PDF]